The FTIR has a detection limit of approximately 5%. Substances below this level may not appear in results — even if they are toxic or affect the potency of your sample.
When possible, we may provide a percentage estimate based on what the FTIR detects. These numbers are generated by software and reflect only the visible components — not the full composition of the sample. The FTIR cannot isolate individual substances in complex mixtures, so any percentage estimates are approximate. They may not reflect actual potency, and similar-looking samples can yield different results – therefore we do not provide purity testing. Any percentages we offer are estimates based on the visible ingredients identified through FTIR spectroscopy. Since this method does not account for the entire sample, undetected ingredients below the detection threshold may influence the composition. The percentages are intended only as a general indication of how the identified ingredients are distributed within the sample. Due to this, any percentages provided cannot be used to calculate milligram quantities within a sample. Our results should not be used to determine exact dosages.
Additionally, a sample may not reflect the full composition of a drug. For example, testing part of a pill may not represent the rest. Cross-contamination between samples stored together can also affect results.
When we detect only one substance, we don’t provide a percentage because other ingredients might still be present below the 5% detection limit.
Treat any percentage result as a rough guideline, not a precise measurement.
Tests highlighted in red indicate particularly dangerous or unexpected results. Flagged samples can alslo be viewed on our Alerts page.
We also use test strips to detect the presence of fentanyl, benzodiazapenes, and lysergamide (LSD).
The results provided are strictly for personal use and educational purposes. They must not be published, distributed, or shared publicly in any form. Unauthorized sharing, reproduction, or publication of these results is strictly prohibited and may result in disciplinary action.
If you find our results shared elsewhere, please be aware that such use is unauthorized and we do not condone it. Images or representations of our results can be easily replicated or altered online, potentially containing misleading or false information. We strongly recommend testing your own samples to ensure accuracy and reliability.
Category: Depressant White Tablet Code: SafeSupplyBarFR
Alprazolam
Microcrystalline Cellulose
Ethylbromazolam
Uncertain Oil
Fentanyl: Negative Benzodiazepine: Positive
Imprint: XANAX/2. Ethylbromazolam is a benzodiazepine derivative; however, there is very little research on its effects or toxicity. Some people have reported that it seems to have a faster onset to that of bromazolam but this has been studied very little and has not been confirmed. It has similar sedative and anxiolytic effects to alprazolam and other benzodiazepines. Since we know very little about its effects, we advise extreme caution with this substance. Taking benzos and opioids together increases the risk of overdose and death. Benzodiazepines are not reversible with naloxone, in case of overdose call 911 and provide rescue breaths.
Regina, SK
09/07/2025
Category: Depressant Brown Granules Code: 19187018
Clobromazolam
Cychlorphine
Fentanyl: Negative Benzodiazepine: Negative
Cychlorphineis a chemical compound which has been sold as a designer drug, reported in five European countries since 2024, and in the USA. It is similar in chemical structure to known opioid agonists such as brorphine and spirochlorphine, and is claimed to be an opioid with similar or slightly higher potency than fentanyl, but no pharmacological data for cychlorphine has been published.